This inventor holds 7 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 1 EPO patent. Top assignee: Nexmed (Holdings) Incorporated. Active years: 2005-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2020
Title: Innovations by Daniel W. Frank: A Pioneer in Raynaud's Disease Treatment
Introduction
Daniel W. Frank, an accomplished inventor based in Broomall, PA, has made significant contributions to the field of medical treatment through his innovative patents. With a total of seven patents to his name, Frank focuses primarily on advancements in therapies for Raynaud's disease. His latest inventions are designed to provide effective relief without the complications often associated with traditional systemic treatments.
Latest Patents
Among his most noteworthy patents are methods and compositions for treating Raynaud's disease. Frank's innovative approach involves topical administration of a semisolid composition that includes a prostaglandin E compound. This method not only offers relief from the symptoms of Raynaud's disease and Raynaud's phenomenon, but it also minimizes the potential complications associated with systemic administration. The semisolid composition can be administered as needed or according to a regimen of several doses throughout the day.
Career Highlights
Daniel W. Frank is currently associated with NexMed Holdings Incorporated, where he applies his expertise in medical innovations. Over the years, his commitment to improving patient care has led him to develop groundbreaking therapies, specifically tailored for individuals suffering from Raynaud's disease. His work exemplifies the intersection of innovation and application in the medical field.
Collaborations
Throughout his career, Frank has collaborated with notable colleagues such as Richard Martin and Bassam Damaj. These partnerships contribute to a collaborative atmosphere where diverse ideas can thrive, ultimately benefiting the healthcare community and patients alike.
Conclusion
Daniel W. Frank stands out as a visionary in the medical application of innovative treatments for Raynaud's disease. His patents reflect a dedicated effort to enhance patient well-being while minimizing treatment complications. As he continues to engage in research and development at NexMed Holdings Incorporated, Frank's contributions will undoubtedly shape the future of therapies targeting Raynaud's disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile